V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10004155 | 10002626 | 1.64 | 97 | Curative (C) | 2017-12-02 | 2017-12-02 | EC | N | Y | 10509858 | TEMOZOLOMIDE + RT |
| 10004156 | 10002626 | 1.68 | 78.1 | Curative (C) | 2018-09-18 | 2018-09-25 | Paclitaxel 7 day | 99 | N | 10509858 | TEMOZOLOMIDE + RT |
| 10004157 | 10002626 | 1.77 | 68 | Adjuvant (A) | 2014-11-26 | 2014-12-02 | ABVD | 02 | N | 10509858 | BCG |
| 10004158 | 10002627 | 1.78 | 90.6 | Adjuvant (A) | null | 2015-03-08 | FEC 100 + DOCETAXEL | N | N | 10510063 | FEC + DOCETAXEL |
| 10004159 | 10002628 | null | 59.5 | Curative (C) | 2017-09-20 | 2017-10-17 | Cisplatin + Radiotherapy | null | Y | 10510084 | CISPLATIN + RT |
| 10004160 | 10002628 | 1.73 | 84.6 | Not known (9) | 2016-11-12 | 2016-11-12 | CHOP - 21 days | 02 | N | 10510084 | CTD |
| 10004161 | 10002628 | 1.63 | 60.7 | Palliative (P) | 2014-01-26 | 2014-02-24 | Irinotecan + Modified De Gramont | N | N | 10510084 | IRINOTECAN + MDG |
| 10004162 | 10008829 | 1.53 | null | Adjuvant (A) | 2018-05-27 | 2018-05-27 | Chlorambucil | N | N | 10510275 | BORTEZOMIB |
| 10004163 | 10009110 | 1.89 | 68.8 | Disease modification (D) | 2017-10-23 | 2017-10-30 | Abiraterone | N | N | 10510318 | BCG |
| 10004164 | 10002629 | 1.58 | 63 | Adjuvant (A) | 2018-05-12 | 2018-05-15 | Imatinib 400mg | N | N | 10510319 | CVD |
| 10004165 | 10002630 | 1.59 | 66.8 | Palliative (P) | 2017-12-19 | 2017-12-26 | Abiraterone | N | N | 10510472 | PACLITAXEL |
| 10004166 | 10002631 | 1.77 | 74 | Curative (C) | 2017-12-02 | 2017-12-02 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | 10510595 | CHLORAMBUCIL |
| 10004167 | 10002632 | 1.79 | 88.4 | Palliative (P) | 2018-08-30 | 2018-09-13 | Irinotecan + Modified De Gramont | 02 | N | 10510691 | IRINOTECAN + MDG |
| 10004168 | 10002633 | 1.54 | null | null | 2015-02-22 | 2015-02-25 | Bortezomib +/- Dexamethasone | 02 | N | 10510766 | BCG |
| 10004169 | 10002634 | 1.71 | 57.9 | null | 2013-08-25 | 2013-09-06 | Temozolomide + RT | 02 | null | 10510843 | CAPECITABINE + CISPLATIN |
| 10004170 | 10002634 | 0 | 0 | Adjuvant (A) | 2018-12-13 | 2018-12-31 | ABVD | N | N | 10510843 | TEMOZOLOMIDE + RT |
| 10004171 | 10002635 | 1.76 | 80 | Adjuvant (A) | 2013-02-03 | 2013-02-15 | BCG Intravesical | 2 | N | 10510953 | CAPECITABINE + GEMCITABINE |
| 10004172 | 10002636 | 1.6 | 56.7 | Palliative (P) | 2016-10-16 | 2016-10-29 | EC | 02 | N | 10511049 | BORTEZOMIB |
| 10004173 | 10002636 | 1.67 | 63.5 | Curative (C) | 2015-12-08 | 2015-12-29 | CHOP - 21 days | 02 | N | 10511049 | ABVD |
| 10004174 | 10002637 | null | 0 | Palliative (P) | null | 2014-02-11 | Fluorouracil + Folinic Acid Weekly | null | N | 10511124 | FLUOROURACIL |
| 10004175 | 10002637 | null | 96 | Palliative (P) | 2016-06-20 | 2016-07-03 | Azacitidine | N | N | 10511124 | TEMOZOLOMIDE + RT |
| 10004176 | 10002638 | 1.56 | null | Adjuvant (A) | 2014-10-13 | 2014-10-13 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 10511315 | CTD |
| 10004177 | 10002639 | null | null | Neo-adjuvant (N) | null | 2016-08-17 | FLUOROURACIL + IRINOTECAN | 99 | N | 10511364 | IRINOTECAN + MDG |
| 10004178 | 10002640 | null | 80.2 | Disease modification (D) | 2017-09-21 | 2017-09-28 | Cisplatin + Etoposide po&iv 3 day | N | N | 10511387 | CHLORAMBUCIL |
| 10004179 | 10002640 | 1.54 | 78.25 | Curative (C) | 2015-09-02 | 2015-09-02 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10511387 | CISPLATIN + ETOPOSIDE |
| 10004180 | 10002641 | 1.68 | 86.8 | Adjuvant (A) | 2015-12-09 | 2015-12-30 | CYCLOPHOSPHAMIDE + EPIRUBICIN | N | N | 10511564 | PACLITAXEL |
| 10004181 | 10006594 | 1.75 | 74.8 | Adjuvant (A) | 2017-05-23 | 2017-05-26 | Azacitidine | N | N | 10511670 | BORTEZOMIB |
| 10004182 | 10006594 | 1.7 | 81.2 | Curative (C) | 2016-04-09 | 2016-05-03 | EC | 2 | N | 10511670 | CAPECITABINE + CISPLATIN |
| 10004183 | 10006594 | null | 77.9 | Palliative (P) | 2017-02-27 | 2017-03-11 | CISPLATIN + ETOPOSIDE | N | N | 10511670 | EC |
| 10004184 | 10009111 | 1.64 | 71.2 | Adjuvant (A) | 2015-01-23 | 2015-01-30 | CISPLATIN + RT | 02 | Y | 10511783 | CISPLATIN + RT |
| 10004185 | 10009111 | 1.6 | 71.6 | Neo-adjuvant (N) | 2015-05-27 | 2015-06-10 | Capecitabine 35days + RT | 2 | Y | 10511783 | CAPECITABINE + RT |
| 10004186 | 10002642 | 1.66 | null | Palliative (P) | 2017-11-13 | 2017-12-23 | Azacitidine | 02 | N | 10511830 | CVD |
| 10004187 | 10002643 | 1.8 | null | Curative (C) | 2017-05-20 | 2017-05-22 | Cisplatin + Radiotherapy | N | null | 10511915 | CISPLATIN + RT |
| 10004188 | 10002644 | 1.54 | 66.6 | Adjuvant (A) | 2017-11-25 | 2017-11-25 | Cisplatin 7 day | 2 | N | 10511921 | CISPLATIN |
| 10004189 | 10002645 | 1.8 | 79.4 | Curative (C) | 2018-01-29 | 2018-01-29 | CAPECITABINE + GEMCITABINE | 02 | N | 10511972 | ABVD |
| 10004190 | 10002646 | 1.54 | 69.5 | Adjuvant (A) | null | 2017-10-12 | MaxiCHOP (Cycle 1) | N | N | 10512018 | ABVD |
| 10004191 | 10002647 | 1.77 | 79.9 | Palliative (P) | 2018-10-25 | 2018-11-02 | Cisplatin | N | N | 10512151 | CVD |
| 10004192 | 10002648 | 1.67 | 86 | Palliative (P) | 2016-04-26 | 2016-05-03 | Paclitaxel 7 day | N | N | 10512202 | ABIRATERONE |
| 10004193 | 10002649 | 1.67 | 82 | Disease modification (D) | 2017-05-14 | 2017-05-28 | Chlorambucil | N | Y | 10512209 | FLUOROURACIL + MITOMYCIN + RT |
| 10004194 | 10002650 | 1.88 | 99.6 | Adjuvant (A) | 2016-10-01 | 2016-10-01 | Fluorouracil + Folinic Acid Weekly | N | N | 10512226 | FLUOROURACIL |
| 10004195 | 10006595 | 1.56 | 84.9 | Curative (C) | 2016-06-02 | 2016-06-02 | CISPLATIN + RT | 02 | null | 10512283 | CISPLATIN + RT |
| 10004196 | 10002651 | null | 51 | Curative (C) | 2016-08-08 | 2016-08-21 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | Y | 10512339 | CTD |
| 10004197 | 10002652 | 1.64 | null | Curative (C) | 2014-10-15 | 2014-10-15 | Gemcitabine + Capecitabine | N | N | 10512345 | CVD |
| 10004198 | 10002653 | 1.61 | 54.7 | Palliative (P) | 2018-03-09 | 2018-03-20 | BCG Intravesical | N | N | 10512503 | ABVD |
| 10004199 | 10002654 | 1.72 | null | Palliative (P) | 2014-12-05 | 2014-12-19 | CVD | 02 | Y | 10512597 | ABIRATERONE |
| 10004200 | 10002654 | 1.74 | 62.6 | Disease modification (D) | 2016-01-14 | 2016-01-28 | Capecitabine + Cisplatin | N | N | 10512597 | AZACITIDINE |
| 10004201 | 10002655 | 1.46 | 91 | Curative (C) | 2014-03-21 | 2014-04-11 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | 10512669 | CISPLATIN + RT |
| 10004202 | 10002656 | 1.8 | 100.4 | Palliative (P) | 2015-03-09 | 2015-03-17 | Capecitabine + Cisplatin | 2 | N | 10512728 | AZACITIDINE |
| 10004203 | 10006597 | 1.63 | 70.6 | Neo-adjuvant (N) | 2014-04-28 | 2014-05-13 | CAPECITABINE + RT | 2 | Y | 10512881 | CAPECITABINE + RT |
| 10004204 | 10002657 | 1.58 | 67.5 | Adjuvant (A) | 2018-03-26 | 2018-04-14 | Gemcitabine + Capecitabine | N | Y | 10512961 | BORTEZOMIB |